GSK Files for Licensure of Priorix MMR Vaccine in the US
August 2, 2021 -- GSK today announced it has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Priorix (Measles, Mumps, and Rubella Virus Vaccine, Live) and is seeking approval for use in active...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news
More News: Drugs & Pharmacology | Food and Drug Administration (FDA) | Measles | Measles Vaccine | Mumps | Mumps Vaccine | New Drug Applications | Rubella | Rubella Vaccine | Vaccines